Michael Melchart
University of Edinburgh
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael Melchart.
Chemical Communications | 2004
Iain W. McNae; Katy Fishburne; Abraha Habtemariam; Tina M. Hunter; Michael Melchart; Fuyi Wang; Malcolm D. Walkinshaw; Peter J. Sadler
The 1.6 [Angstrom] X-ray crystal structure of [(eta(6)-p-cymene)Ru(lysozyme)Cl(2)], the first of a half-sandwich complex of a protein, shows selective ruthenation of Nepsilon of the imidazole ring of His15.
Inorganic Chemistry | 2010
Ana M. Pizarro; Michael Melchart; Abraha Habtemariam; Luca Salassa; Francesca P. A. Fabbiani; Simon Parsons; Peter J. Sadler
The closed- and open-tethered Ru(II) eta(6)-arene complexes [Ru(II)(eta(6):eta(1)-C(6)H(5)(C(6)H(4))NH(2))(en)]Cl(2) (2) and [Ru(II)(eta(6)-C(6)H(5)(C(6)H(4))NH(2))Cl(en)]Cl (3), where en is ethylenediamine, have been synthesized and their X-ray structures determined. Interconversion between 2 and 3, that is, tethered-arene ring-closure and ring-opening, in different solvents has been investigated. Complex 2 opens in dimethylsulfoxide (DMSO) by solvent-induced dissociation of the NH(2) group of the pendant arm. In methanol, however, equilibrium between 2 and 3 is reached after 12 h when both species coexist in solution in a ratio of 2:1 (open/closed). In water (pH 7), complete ring closure of 3 to 2 at 298 K occurs in less than 2 h. The tether ring of complex 2 opens at basic pH and closes at neutral pH. Complex 2 opens over time (18 h) in concentrated HCl. The opening-closing process is fully reversible in the pH range 2-12. Density Functional Theory calculations have been used to obtain insights into the electronic structure of complexes 2 and 3, their UV-vis properties, and their stability compared to their aqua derivatives. Control of tether-ring-opening can contribute toward a strategy for activation and for achieving cytotoxic selectivity of ruthenium arene anticancer drugs.
Chemical Communications | 2005
Yaw Kai Yan; Michael Melchart; Abraha Habtemariam; Peter J. Sadler
Journal of Medicinal Chemistry | 2006
Abraha Habtemariam; Michael Melchart; Rafael Fernández; Simon Parsons; Iain D. H. Oswald; Andrew Parkin; Francesca P. A. Fabbiani; James Davidson; Alice Dawson; Rhona E. Aird; Duncan I. Jodrell; Peter J. Sadler
Proceedings of the National Academy of Sciences of the United States of America | 2005
Fuyi Wang; Abraha Habtemariam; E P L van der Geer; Rafael Fernández; Michael Melchart; Robert J. Deeth; Rhona E. Aird; S.M. Guichard; Francesca P. A. Fabbiani; P Lozano-Casal; Iain D. H. Oswald; Duncan I. Jodrell; Simon Parsons; Peter J. Sadler
Chemistry: A European Journal | 2004
Rafael Fernández; Michael Melchart; Abraha Habtemariam; Simon Parsons; Peter J. Sadler
Chemistry: A European Journal | 2007
Anna F. A. Peacock; Michael Melchart; Robert J. Deeth; Abraha Habtemariam; Simon Parsons; Peter J. Sadler
Inorganic Chemistry | 2006
Sarah J. Dougan; Michael Melchart; Abraha Habtemariam; Simon Parsons; Peter J. Sadler
Inorganic Chemistry | 2007
Michael Melchart; Abraha Habtemariam; Olga Novakova; Stephen A. Moggach; Francesca P. A. Fabbiani; Simon Parsons; Viktor Brabec; Peter J. Sadler
Journal of Biological Inorganic Chemistry | 2006
Yaw Kai Yan; Michael Melchart; Abraha Habtemariam; Anna F. A. Peacock; Peter J. Sadler